| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 8.24 Billion | USD 19.69 Billion | 9.10% | 2024 |
FrequentlyAsked Questions
Medical device contract research organizations (CRO) are strategic partners to medical device companies.
The global medical device CRO market is expected to be driven by the changing landscape across the globe concerning the regulatory framework for medical devices.
According to study, the global medical device CRO market size was worth around USD 8.24 billion in 2024 and is predicted to grow to around USD 19.69 billion by 2034.
The CAGR value of the medical device CRO market is expected to be around 9.10% during 2025-2034.
The global medical device CRO market is expected to be led by North America during the projection period.
The global medical device CRO market is led by players like Laboratory Corporation of America Holdings (Labcorp), IQVIA Inc., Medpace Holdings, Inc., Syneos Health, PAREXEL International, Eurofins Scientific SE, CROMSOURCE, Qserve Group, ICON plc, Fortrea Holdings Inc., Charles River Laboratories, Promedica International, WuXi AppTec, Avania, and NAMSA.
The report explores crucial aspects of the medical device CRO market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients